Tumorigenicity of a rabbit lymphoid cell line transformed by human T-cell leukemia virus. NLM AIDSLINE Important note: Information in this article was accurate in 1984. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Tumorigenicity of a rabbit lymphoid cell line transformed by human T-cell leukemia virus.

Gann. 1984 Jun;75(6):482-4. Unique Identifier : AIDSLINE MED/84286555
Miyoshi I; Kubonishi I; Yoshimoto S; Ohtsuki Y; Akagi T


Abstract: A rabbit lymphoid cell line transformed by human T-cell leukemia virus (HTLV) was inoculated into the peritoneal cavity of six newborn hamsters treated by antilymphocyte serum. All of them developed lethal tumors two weeks after implantation. The tumor cells were chromosomally of rabbit type, and harbored HTLV and HTLV antigens.
Keywords: Animal Animals, Newborn Antilymphocyte Serum/PHARMACOLOGY Cell Line *Cell Transformation, Viral Chromosomes/ULTRASTRUCTURE Hamsters HTLV-BLV Viruses/*PATHOGENICITY Lymphocytes/MICROBIOLOGY Neoplasm Transplantation Neoplasms, Experimental/*ETIOLOGY/GENETICS Rabbits Support, Non-U.S. Gov't JOURNAL ARTICLE

KWDanimalanimals,newbornantilymphocyteserum/pharmacologycelllineKWDcelltransformation,viralchromosomes/ultrastructurehamstershtlv-blvviruses/KWDpathogenicitylymphocytes/microbiologyneoplasmtransplantationneoplasms,experimental/KWDetiology/geneticsrabbitssupport,non-uKWDsKWDgov'tjournalarticle
841230
M84C0039


Copyright © 1984 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1984. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1984. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .